The results showed that the inhibitor could effectively interfere with memory consolidation, but had no effect on memory reconsolidation. ‘Our results show the different effects of specifically inhibiting the initiation of protein synthesis on memory consolidation and reconsolidation, so clearly these two processes in a greater variation than previously thought,’said Eric Klann, a professor at NYU’s Center for Neural Science and one of the study co-authors. ‘Because addressing memory-related ailments, such as PTSD, depends on first understanding the nature of memory formation and the playback of those memories may find remedies as even more difficult than currently recognized.
As a result,age, reactivation process more complex than previously believedThe process we use to store memories is more complex than previously thought, New York University neuroscientists have found. Their research, which appears in the journal the Proceedings of the National Academy of Sciences, underscores the challenges in addressing memory-related disorders, such as post – traumatic stress disorder.Plexxikon has that phase 1 dose of – escalation study percent regresivity with PLX4032 of for melanoma further the high selectivity of PLX4032 have activate us dose of virtually complete destination inhibit as such a treatment been fine tolerated by most patients. ‘.